Le Lézard
Classified in: Health, Science and technology
Subject: SVY

Global Bioinks Market Overview and Outlook, 2018-2019 & 2024


DUBLIN, Jan. 29, 2020 /PRNewswire/ -- The "Bioinks: The Living Foundation of Functional Bioprinting" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

This report includes:

The term bioprinting refers to the utilization of additive manufacturing to create 3D structures that contain one or more types of living cells as well as other substances such as growing factors and biomaterials. These structures (also known as scaffolds) are designed to mimic natural tissues and, possibly, organs. Actually, scaffolds can be of two types: acellular, in which cells are seeded after printing (top-down approach); and cellular, in which the cells are printed together within the scaffold material (bottom-up approach). Bioprinting is associated with the bottom-up approach.

Until now, bioprinting has not yet been able to create complete, fully functional organs, but it has been utilized to produce small-scale tissue constructs and miniature simplified version of organs, known as organoids. Reproduction of human organs is naturally expected to raise many ethical issues. In the meantime, bioprinted structures are finding application in drug development, tissue engineering, toxicology screening, pathology modeling, and customized cancer treatment. Bioprinting is achieving large interest in the biomedical field due to its capability to produce tissues on-demand and in-situ.

Key Topics Covered

Chapter 1 Technology Highlights and Market Outlook

List of Tables
Table 1: Global Market for 3D Printing, by Application, Through 2024
Table 2: Bioprinting Technologies
Table 3: Applications of Bioinks
Table 4: Current and Emerging Trends in Bioink Technology
Table 5: Global Market for Bioinks, by Region, Through 2024

List of Figures
Figure 1: Global Market Shares of 3D Printing, by Application, 2024
Figure 2: Global Market Share for Bioinks, by Region, 2024

For more information about this report visit https://www.researchandmarkets.com/r/o23kst

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

19 avr 2024
Remedium Healthcare Products is proud to announce the launch of NuVeria Labs' revolutionary Sacral Silicone Dressing, now available for purchase on Amazon, bringing advanced wound care solutions directly to consumers' doorsteps. Designed to address...

19 avr 2024
Getting specialty medications into...

19 avr 2024
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards. "This product, along with our other innovations,...

19 avr 2024
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...

19 avr 2024
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...

19 avr 2024
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...



News published on and distributed by: